ArticleContemporary oncology (Poznan, Poland)2023

Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.

Piotr Domański et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.